The Life Sciences Products segment focuses on the research, development, manufacturing, and marketing of products and tools for clinical research, drug development, and bioscience research. This segment provides a wide array of products, including proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits. These tools are essential for life science researchers in target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. Enzo's products are utilized by experts in various fields, such as cancer, cardiovascular disease, neurological disorders, diabetes, infectious diseases, and autoimmune diseases. The segment's competitive advantage lies in its proprietary technologies and broad product portfolio, enabling it to serve a diverse customer base and support advancements in various areas of biomedical research. Future opportunities include expanding the product portfolio and entering new therapeutic areas.

The Clinical Laboratory Services segment offers molecular and other clinical laboratory tests and procedures used in patient care to aid in diagnosis, treatment monitoring, and the detection of undiagnosed conditions. Enzo operates a full-service clinical laboratory in Farmingdale, New York, along with a network of patient service centers in New York and New Jersey. Additionally, they have rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. This segment utilizes advanced molecular diagnostic techniques and technologies to provide accurate and timely results, impacting patient outcomes by enabling physicians to make informed decisions. The segment's market position is strengthened by its comprehensive service offerings and strategic locations. Future growth opportunities include expanding the test menu, increasing the number of patient service centers, and leveraging technological advancements in diagnostics.

The Therapeutics segment is dedicated to developing novel approaches for treating gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo focuses on research and development to create innovative therapeutic solutions. The company leverages its expertise in molecular biology and biotechnology to identify and develop potential drug candidates. This segment's research and development activities include drug discovery, preclinical studies, and clinical trials. Enzo markets its products and services through a direct sales force and a network of distributors in the United States and internationally. The segment's focus on specific disease areas allows for targeted research and development efforts, potentially leading to improved patient outcomes. Future opportunities include expanding the therapeutic pipeline and forming strategic partnerships to accelerate drug development and commercialization.